POSITION OVERVIEW:
Reporting to the Director of Research, the Radiochemist Scientist will participate as a key member of the ImaginAb Research Team by taking responsibility for running radiolabeling experiments of antibody fragments and perform all necessary characterizations. This role will optimize new conjugations with metal chelators and develop QC assays across multiple projects against different cancer targets. Draft technical reports and SOPs, and support transfer of such processes to external collaborators. This position is part of a cross functional team and supports different activities such as production of radiolabeled samples for in-vivo experiments, as well as scale-up conjugation reactions for process development.
ESSENTIAL JOB FUNCTIONS:
Radiolabeling with radioisotopes for imaging and radiotherapy
Preparation of protein / small molecule conjugates, such as antibodies, minibodies or cys-diabodies, with metal chelators or fluorescence dyes
Conjugation process development to support scale-up production and manufacturing development.
Hands-on experience handling radioactive samples, and knowledge of radiation safety regulations
Conjugation process improvement for identification of novel chelators
Preparation and testing of other chemistry related reagents and solutions
Characterization and QC assays of antibody conjugates including SE-HPLC, RP-HPLC, icIEF, SDS-PAGE, UV-Vis, ELISA, flow cytometry
Writing batch records, SOPs, and technical development reports
Presentation of work at internal meeting
Assist with process transfers to CMOs or external partners
Document and data management
Contribute to drafting publications and posters as needed
Other responsibilities as assigned
REQUIRED EDUCATION AND EXPERIENCE:
PHYSICAL AND MENTAL REQUIREMENTS:
WORK ENVIRONMENT:
SALARY AND BENEFITS
Salary commensurate with experience and robust benefits package offered. Inclusive and great team environment. Resumes through search firms will not be accepted.
ABOUT IMAGINAB
ImaginAb are world leaders in the development of immunoPET and our late-stage imaging agent is utilized in a rapidly increasing number of trials. Alongside ImaginAb sponsored studies, we work with some of the world’s largest pharmaceutical companies and most innovative biotech’s to study CD8+ cell distribution in patients prior to and during immunotherapy, to better understand the action of this critical class of cancer medicine.
Join us as we reimagine a new vision and approach towards immune-oncology patient care paths. Explore more about who we are, how we innovate for tomorrow, and why partnering with us will help to challenge, create, and transform patient care at https://imaginab.com/
ImaginAb, Inc. is an equal opportunity employer, we evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, veteran status, or any other legally protected characteristics.